The future of Biogen’s potential blockbuster Alzheimer’s treatment was thrown back into doubt on Friday when an unusually combative scientific panel contradicted the positive conclusions of staff at … [+3120 chars]
Biogen Alzheimers drug in doubt after criticism from expert panel – Financial Times
